Genetic susceptibility to Kawasaki disease: Analysis of pattern recognition receptor genes

Human Immunology

Volumn 73, Issue 6, 2012, Pages 654-660

  Onoyama, Sagano ^a   Ihara, Kenji ^a   Yamaguchi, Yui ^a   Ikeda, Kazuyuki ^a   Yamaguchi, Kenichiro ^a   Yamamura, Kenichiro ^a   Hoshina, Takayuki ^a   Mizuno, Yumi ^b   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA CHILDREN S HOSPITAL   (Japan)

Author keywords

Innate immunity; Kawasaki disease; NLRP1 gene; NOD1 gene; Pattern recognition receptors

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 4; NLRP1 PROTEIN; PATTERN RECOGNITION RECEPTOR; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INNATE IMMUNITY; JAPANESE; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ALLELES; APOPTOSIS REGULATORY PROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NOD1 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84861785787     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.03.011     Document Type: Article

References (33)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi=[Allergy] 1967, 16:178-222.
2. Jennette J.C., Sciarrotta J., Takahashi K., Naoe S. Predominance of monocytes and macrophages in the inflammatory infiltrates of acute Kawasaki disease arteritis. Pediatr Res 2003, 53:173.
3. Takahashi K., Oharaseki T., Naoe S., Wakayama M., Yokouchi Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int Off J Jpn Pediatr Soc 2005, 47:305-310.
4. Brown T.J., Crawford S.E., Cornwall M.L., Garcia F., Shulman S.T., Rowley A.H. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Inf Dis 2001, 184:940-943.
5. Kato H., Sugimura T., Akagi T., Sato N., Hashino K., Maeno Y., et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996, 94:1379-1385.
6. Yanagawa H., Nakamura Y., Yashiro M., Fujita Y., Nagai M., Kawasaki T., et al. A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. J Inf Dis 1988, 158:1296-1301.
7. Onouchi Y., Gunji T., Burns J.C., Shimizu C., Newburger J.W., Yashiro M., et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008, 40:35-42.
8. Lee J.K., Kim J.J., Hong Y.M., Sohn S., Jang G.Y., Ha K.S., et al. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum Genet 2011, 129:487-495.
9. Nakamura Y., Yashiro M., Uehara R., Sadakane A., Chihara I., Aoyama Y., et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol/Jpn Epidemiol Assoc 2010, 20:302-307.
10. Ikeda K., Yamaguchi K., Tanaka T., Mizuno Y., Hijikata A., Ohara O., et al. Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin Exp Immunol 2010, 160:246-255.
11. Popper S.J., Shimizu C., Shike H., Kanegaye J.T., Newburger J.W., Sundel R.P., et al. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biology 2007, 8:R261.
12. Nishio H., Kanno S., Onoyama S., Ikeda K., Tanaka T., Kusuhara K., et al. Nod1 ligands induce site-specific vascular inflammation. Arteriosclerosis, Thromb Vasc Biology 2011, 31:1093-1099.
13. Onouchi Y., Ozaki K., Buns J.C., Shimizu C., Hamada H., Honda T., et al. Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet 2010, 19:2898-2906.
14. Khor C.C., Davila S., Breunis W.B., Lee Y.C., Shimizu C., Wright V.J., et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 2011.
15. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
16. Golenbock D.T., Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000, 105:497-504.
17. Golenbock D.T., Lien E., Sellati T.J., Yoshimura A., Flo T.H., Rawadi G., et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999, 274:33419-33425.
18. Arditi M., Bulut Y., Faure E., Thomas L., Equils O. Cooperation of toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001, 167:987-994.
19. Philpott D.J., Girardin S.E., Boneca I.G., Carneiro L.A.M., Antignac A., Jehanno M., et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003, 300:1584-1587.
20. Nunez G., Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J Biol Chem 2003, 278:5509-5512.
21. Dziarski R., Gupta D. Mammalian PGRPs: novel antibacterial proteins. Cell Microbiol 2006, 8:1059-1069.
22. Inohara N., Chamaillard M., Hashimoto M., Horie Y., Masumoto J., Qiu S., et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003, 4:702-707.
23. Nunez G., Inohara N., Koseki T., del Peso L., Hu Y.M., Yee C., et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappa B. J Biol Chem 1999, 274:14560-14567.
24. Inohara N., Masumoto J., Yang K., Varambally S., Hasegawa M., Tomlins S.A., et al. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med 2006, 203:203-213.
25. Averette K.M., Pratt M.R., Yang Y.A., Bassilian S., Whitelegge J.P., Loo J.A., et al. Anthrax lethal toxin induced lysosomal membrane permeabilization and cytosolic cathepsin release Is Nlrp1b/Nalp1b-dependent. PloS One 2009, 4.
26. Drenth J.P.H., van der Meer J.W.M. The inflammasome - a linebacker of innate defense. New Engl J Med 2006, 355:730-732.
27. McGovern D.P.B., Hysi P., Ahmad T., van Heel D.A., Moffatt M.F., Carey A., et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 2005, 14:1245-1250.
28. Cookson W.O.C., Hysi P., Kabesch M., Moffatt M.F., Schedel M., Carr D., et al. NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 2005, 14:935-941.
29. Jones J.D.G., Dixon M.S., Hatzixanthis K., Jones D.A., Harrison K. The tomato Cf-5 disease resistance gene and six homologs show pronounced allelic variation in leucine-rich repeat copy number. Plant Cell 1998, 10:1915-1925.
30. Spritz R.A., Jin Y., Mailloux C.M., Gowan K., Riccardi S.L., LaBerge G., et al. NALP1 in vitiligo-associated multiple autoimmune disease. New Engl J Med 2007, 356:1216-1225.
31. Pontillo A., Vendramin A., Catamo E., Fabris A., Crovella S. The missense variation Q705K in CIAS1/NALP3/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease. Am J Gastroenterology 2011, 106:539-544.
32. McLeod R., Witola W.H., Mui E., Hargrave A., Liu S.S., Hypolite M., et al. NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of toxoplasma gondii-infected monocytic cells. Infect Immun 2011, 79:756-766.
33. Yeung R.S. Phenotype and coronary outcome in Kawasaki's disease. Lancet 2007, 369:85-87.